Localized radiation therapy appeared safe before treatment with chimeric antigen receptor T cells for relapsed or refractory multiple myeloma, according to study results presented at the virtual ASTRO Annual Meeting.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.